JEFFREY (JEFF) NORDQUIST, MS, MBA

Dallas, TX | 224-223-5251 | jeffrey.s.nordquist@alumni.stanford.edu | linkedin.com/in/jsnordquist

VICE PRESIDENT - INNOVATION | PRODUCT DEVELOPMENT | MARKETING

International innovation, product development, and marketing executive with demonstrated expertise across
products, services, and strategic partnerships with focus on technological advances for safety, efficiency, and
enhanced customer experience. Valued as a "Business Scientist" who unites technical and business proficiencies to
propel innovation and growth. Drives product innovation and commercial strategy in collaboration with key
stakeholders to build customer centric excellence.

KEY EXECUTIVE COMPETENCIES

New Product Innovation | Corporate Strategy | B2B & B2C Marketing | B2B Sales | Customer Experience (CX)
R&D Product Development | Change Management | Cross Functional Team Leadership | Consulting
Business Transformation | Private Equity Leadership | Lean Six Sigma | Human Centered Design
Continuous Improvement | Intellectual Property Strategy

PROFESSIONAL EXPERIENCE
AMERISOURCEBERGEN, Carrollton, TX (Fortune 10) 2016 – 2022
Vice President, Customer Product Development and Innovation, 2020 - 2022
Drove new product innovation through human centered design by directly working with customers to determine
needs and preference, in collaboration with the corporate strategy team, transformation office, and commercial
leaders. Efforts resulted in more than 30 new solutions explored with customers in the areas of SaaS, inventory
management, data and analytics, revenue cycle management, and operational efficiency.
 Via change management, activated a product life cycle stage-gate process from ideation to product sunset
which ensured new product ideas were translated to product requirements for the R&D teams, developed, and
launched based on customer empathy and needs.
 Integral member of the team who built the Customer Experience Center of Excellence to intentionally design a
holistic customer experience (CX) influencing customer adoption, utilization, and loyalty by partnering with
multiple consulting firms, including McKinsey, Bain, and Accenture.
 Architected unique Voice of Customer (VOC) monitoring and measuring programs during new product
MVP/MLP pilots to inform continuous improvement for new product and service launches.
 Created the AmerisourceBergen Consulting Community, a customer community focused on sharing ideas and
answering key commercial questions for innovation and customer engagement projects.

Vice President, B2B/B2C Product Marketing, 2019 - 2020

Led dedicated Marketing team (27 strong) driving over $100 billion in commercial sales within national account
health systems, specialty physicians (oncology, ophthalmology), GPOs, and patients through integrated marketing
campaigns (e.g. advertising, public relations, digital/social, content marketing, and event marketing).
 Achieved 20-27% growth YOY in targeted business units.
 Drove product development and design for community oncology products that face B2B and B2C markets.
 Utilizing agile process, drove organizational design work to enable shift to centralized, shared services model
for Marketing across the enterprise, including standardization of operating mechanisms and tools.

Vice President, Marketing, Business Development, and Customer Service, 2016 - 2019
Inspired robust rebranding, repositioning, and message development following acquisition of the 503B compounding
business, achieving 88% of outsourcing customers purchasing from PharMEDium (2018).
 Ideated and built Customer Experience Centers (CECs) within flagship manufacturing facilities to activate
Customer Visit Program, including creation of a sales team deployed, Virtual Reality (VR) experience.
 Advanced American Health Packaging (AHP) to leading position for BCMA barcoded unit-dose products.
 Identified adjacencies for business expansion and growth (pharma manufacturer and hospital targets).
 Led compounded pharmacy customer service team to achieve Certified Center of Excellence distinctions.
 Championed safety labeling leadership through embedded RFID tags and inventor for patented IV line labels.
Jeff Nordquist jeffrey.s.nordquist@alumni.stanford.edu Page Two

CORPAK MEDSYSTEMS/HALYARD/AVANOS, Buffalo Grove, IL (Private Equity) 2013 – 2016

Vice President, Global Product Marketing & Business Development, 2013 - 2016
Reported to CEO, leading marketing vision, strategy, and execution for global product lines for US and UK teams.
 Transformed industry parity 2-3% growth into 12% and 13% respectively in the first 2 full years (2014-2015).
 Unified corporate brand and unique value proposition as the “Preferred Enteral Partner”.
 Developed and launched new corporate website and the Corpak University™ customer training platform.
 Drove Corflo® feeding tubes as market leader and adoption of Cortrak® Enteral Access System technology.
 Chief catalyst for Intellectual Property implementation, including over 20 new patent applications (11 as
inventor), 19 new brand marks, and trade dress protection for the color yellow for feeding tubes.

BAXTER HEALTHCARE, Deerfield, IL (Fortune 300) 2001 – 2013

Vice President, B2B & National Accounts Marketing, 2010 - 2013
Directed marketing and strategy for U.S. acute hospital and alternate site channels including pharmaceuticals,
nutrition, drug delivery, compounding, and I.V. solutions with team of 20+ marketing professionals.
 Drove 12%+ CAGR growth with diverse $1.5 billion portfolio by partnering with 200+ sales force and
developing targeted marketing programs to increase sales velocity.
 Led regional integration of Baxa acquisition and re-launching $150+ million business.
 Team awarded the 2010 Baxter Chairman’s Award for outstanding business results.

Vice President, Marketing & Business Development, 2007 - 2010

Led commercial growth for the pharmaceutical, drug delivery, I.V. solutions, and multi-source generic franchises.
 Achieved 7% pretax improvement by streamlining $370 million generic drug vial franchise and establishing
new commercial strategy that led to the successful divestiture to West-Ward Pharmaceuticals.
 Garnered 40% premium on high-alert generic drugs by developing and launching Clear-ID® labeling.
 Reinvigorated 30-year old Viaflex® platform by leveraging Enlightened® bar code technology.

Vice President, U.S. Region Marketing, 2003 - 2007

Directed team of 40+ marketing, communications, and clinical professionals for the Pharmacy and Medication
Delivery product portfolios including pharmaceuticals, medical devices, and hardware.
 Attained over $100 million in price increases over three years by creating the regional “Pricing Office”.
 Retained 90%+ of business after the Colleague® pump recall.

Senior Director, Strategic R&D Partnerships, 2002 - 2003 | Director, Strategic R&D Partnerships, 2001 - 2002
Spearheaded regional commercial growth for drug delivery business and pharmaceutical company partnerships.

ADDITIONAL RELEVANT EXPERIENCE

PFIZER/SEARLE PHARMACEUTICALS, Skokie, IL (Fortune 50)
Director, Global Marketing | Associate Director, Global Marketing
Drove global commercialization efforts for COX-2 Technology compounds (Celebrex®, Bextra®, Dynastat®).
 Achieved $1.4 billion in first year sales and 20% market expansion by driving the Celebrex® pre-launch
strategy and initiatives, creating the most successful pharmaceutical launch of its time.

EDUCATION | PROFESSIONAL DEVELOPMENT

M.B.A., Marketing, Northwestern University, Evanston, IL
M.S., Mechanical Engineering with Research Assistantship, Stanford University, Palo Alto, CA
B.S., Mechanical Engineering with Bronze Tablet Honors, University of Illinois, Urbana-Champaign, IL
Kellogg Executive Scholar (Northwestern University) and Wharton Executive Education (University of Pennsylvania)

BOARD EXPERIENCE | COMMUNITY LEADERSHIP

Board President, Board Vice-President (Illinois Unit District #220 School Board, Barrington, IL)
 Elected (Illinois general election) to 3 consecutive 4-year terms.
 Led District from negative fund balance to one in excess of 25% while enrollment increased by 22%, achieving
S&P rating of AAA with annual budget of $110+ million.